DROR Dror Ortho-Design, Inc.
Dental Equipment & Supplies · OTC · SEC CIK 1282980 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY25.0%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-852.0%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets1,702.6%
Debt / equity—
Current ratio0.06x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.73x
Accruals ratio-225.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| R&D expense | $119,261 | $150,769 | $118,410 | $100,774 | $151,456 | $324,068 | $239,604 | $326,194 |
| SG&A expense | $320,925 | $344,997 | $378,784 | $344,369 | $318,424 | $391,494 | $313,629 | $411,401 |
| Operating income | -$440,186 | -$495,766 | -$497,194 | -$445,143 | -$469,880 | -$731,539 | -$576,426 | -$1.13M |
| Pretax income | -$520,888 | -$625,143 | -$638,666 | -$555,898 | -$653,528 | -$759,338 | -$576,123 | -$1.13M |
| Net income | -$520,888 | -$625,143 | -$638,666 | -$555,898 | -$653,528 | -$759,338 | -$576,123 | -$1.13M |
| EBITDA | -$438,872 | -$494,451 | -$495,880 | -$443,902 | -$468,625 | -$730,324 | -$575,191 | -$1.13M |
| EPS (basic) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| Weighted avg. shares (diluted) | 977.00M | 977.00M | 976.10M | — | 957.00M | 957.00M | 957.00M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $25,046 | $93,563 | $23,802 | $228,540 | $240,362 | $64,481 | $349,851 | $549,444 |
| Current assets | $261,988 | $348,156 | $234,933 | $238,774 | $250,781 | $110,924 | $420,383 | $638,583 |
| PP&E, net | $16,219 | $17,533 | $18,848 | $20,162 | $20,437 | $21,692 | $22,907 | $24,142 |
| Total assets | $278,207 | $365,689 | $253,781 | $258,936 | $271,218 | $132,616 | $443,290 | $662,725 |
| Current liabilities | $4.53M | $4.10M | $3.38M | $2.96M | $2.42M | $1.64M | $1.23M | $906,738 |
| Total liabilities | $4.74M | $4.30M | $3.57M | $3.13M | $2.59M | $1.80M | $1.36M | $1.03M |
| Shareholders' equity | -$4.46M | -$3.94M | -$3.31M | -$2.87M | -$2.32M | -$1.66M | -$920,924 | -$367,994 |
| Shares outstanding | 977.00M | 977.00M | 977.00M | 957.00M | 957.00M | 957.00M | 957.00M | 957.00M |
| Cash flow statement | ||||||||
| Operating cash flow | -$361,983 | -$304,751 | -$404,268 | -$648,963 | -$424,119 | -$485,370 | -$499,593 | -$563,097 |
| Capital expenditure | — | — | — | — | — | — | — | $0 |
| Free cash flow | — | — | — | — | — | — | — | -$563,097 |
| Investing cash flow | — | — | — | — | — | — | — | $0 |
| Financing cash flow | $295,000 | $375,000 | $200,000 | $650,000 | $600,000 | $200,000 | $300,000 | — |
| Depreciation & amortization | $1,314 | $1,315 | $1,314 | $1,241 | $1,255 | $1,215 | $1,235 | $1,235 |
| Stock-based compensation | — | — | — | $0 | $0 | $15,977 | $23,193 | $391,307 |
Free plan shows the latest 8 periods; Pro shows all 31 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.